Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model.
<h4>Background</h4>Over 14 million people die each year from infectious diseases despite extensive vaccine use [1]. The needle and syringe--first invented in 1853--is still the primary delivery device, injecting liquid vaccine into muscle. Vaccines could be far more effective if they wer...
Saved in:
Main Authors: | Germain J P Fernando, Xianfeng Chen, Tarl W Prow, Michael L Crichton, Emily J Fairmaid, Michael S Roberts, Ian H Frazer, Lorena E Brown, Mark A F Kendall |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2010
|
Subjects: | |
Online Access: | https://doaj.org/article/513f0894b14147b3946ebd930b55e4f0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases.
by: Anwar M Hashem, et al.
Published: (2009) -
EGF and curcumin co-encapsulated nanoparticle/hydrogel system as potent skin regeneration agent
by: Li X, et al.
Published: (2016) -
A framework to guide dose & regimen strategy for clinical drug development
by: Oliver Sander, et al.
Published: (2021) -
Potent sialic acid inhibitors that target influenza A virus hemagglutinin
by: Yu-Jen Chang, et al.
Published: (2021) -
Network-Guided Discovery of Influenza Virus Replication Host Factors
by: Emily E. Ackerman, et al.
Published: (2018)